GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Contec Medical Systems Co 300869.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

9.81

-1.51%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥468.0m

FY2016FY2025

Net income

−CN¥24.4m

FY2016FY2025

Free cash flow

−CN¥27.2m

FY2016FY2025

Shareholders' equity

CN¥1.73bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥468.0mCN¥479.8mCN¥746.9mCN¥712.1mCN¥908.7mCN¥1.40bnCN¥387.2mCN¥362.7mCN¥397.8mCN¥442.1m
Research and developmentCN¥91.7mCN¥105.2mCN¥110.6mCN¥93.3mCN¥66.1mCN¥48.7mCN¥40.6mCN¥34.4mCN¥35.0mCN¥38.3m
Operating income−CN¥14.0m−CN¥67.6mCN¥186.7mCN¥219.3mCN¥405.7mCN¥714.6mCN¥81.6mCN¥69.5mCN¥84.6mCN¥96.8m
Net income−CN¥24.4m−CN¥77.9mCN¥165.8mCN¥196.2mCN¥352.4mCN¥613.4mCN¥73.8mCN¥62.0mCN¥77.1mCN¥103.5m
Diluted earnings per share-0.07-0.180.400.500.881.530.180.180.210.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥2.77bnCN¥2.73bnCN¥3.21bnCN¥3.73bnCN¥2.79bnCN¥2.10bnCN¥679.2mCN¥575.4mCN¥554.1mCN¥495.0m
Cash and short-term investments—CN¥855.9mCN¥1.96bnCN¥1.44bnCN¥624.0mCN¥814.1mCN¥184.3mCN¥241.8mCN¥225.6mCN¥166.7m
Total liabilitiesCN¥1.04bnCN¥868.1mCN¥1.17bnCN¥1.80bnCN¥969.0mCN¥529.0mCN¥96.0mCN¥66.1mCN¥107.6mCN¥123.9m
DebtCN¥749.1mCN¥785.4mCN¥1.05bnCN¥1.58bnCN¥804.3mCN¥267.9mCN¥18.9m—CN¥576,500CN¥844,600
Shareholders' equityCN¥1.73bnCN¥1.86bnCN¥2.04bnCN¥1.93bnCN¥1.82bnCN¥1.57bnCN¥583.2mCN¥509.2mCN¥446.5mCN¥371.0m
Shares outstanding358m432m412m396m402m400m403m337m360m369m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥22.3mCN¥62.3mCN¥181.0mCN¥103.7mCN¥4.6mCN¥597.7mCN¥50.2mCN¥29.8mCN¥117.6mCN¥130.6m
Capital spending−CN¥49.5m−CN¥54.5m−CN¥30.7m−CN¥81.4m−CN¥106.3m−CN¥88.7m−CN¥7.4m−CN¥11.9m−CN¥3.1m−CN¥13.7m
Free cash flow−CN¥27.2mCN¥7.9mCN¥150.3mCN¥22.2m−CN¥101.7mCN¥509.1mCN¥42.8mCN¥17.9mCN¥114.6mCN¥117.0m
Dividends paid−CN¥112.1m−CN¥127.7m−CN¥68.7m−CN¥120.5m−CN¥102.3m−CN¥1.9m−CN¥1.9m−CN¥1.9m−CN¥1.9m−CN¥122.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥125.6mCN¥100.3mCN¥124.0mCN¥126.4mCN¥105.7mCN¥111.8mCN¥145.9mCN¥122.1m
Operating income−CN¥1.7m−CN¥1.9m−CN¥30.1m−CN¥8.3mCN¥1.1mCN¥17.2m−CN¥78.0mCN¥5.1m
Net income−CN¥41.0m−CN¥8.2m−CN¥33.8m−CN¥7.5mCN¥501,803CN¥16.4m−CN¥87.8mCN¥1.7m
Diluted earnings per share-0.11-0.02-0.09-0.020.000.05-0.200.00
Cash from operations———CN¥4.0m−CN¥4.0mCN¥29.0m—CN¥31.0m
Capital spending−CN¥5.0m−CN¥3.0m−CN¥16.0m−CN¥9.0m−CN¥17.0m−CN¥5.0m−CN¥17.0m−CN¥6.0m
Free cash flow———−CN¥5.0m−CN¥21.0mCN¥24.0m—CN¥25.0m
Total assetsCN¥2.64bnCN¥2.79bnCN¥2.77bnCN¥2.79bnCN¥2.77bnCN¥2.79bnCN¥2.73bnCN¥2.83bn
Cash and short-term investments———CN¥1.41bnCN¥1.38bnCN¥1.42bnCN¥855.9mCN¥1.21bn
DebtCN¥766.4mCN¥757.7mCN¥749.1mCN¥198.6mCN¥905.3mCN¥823.2mCN¥783.5mCN¥805.1m
Shareholders' equityCN¥1.68bnCN¥1.72bnCN¥1.73bnCN¥1.77bnCN¥1.77bnCN¥1.87bnCN¥1.86bnCN¥1.93bn

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin2.3%-7.7%31.3%33.7%45.3%51.3%
Net margin-5.2%-16.2%22.2%27.6%38.8%43.8%
Return on equity-1.4%-4.2%8.1%10.2%19.4%39.1%
Return on assets-0.9%-2.9%5.2%5.3%12.6%29.2%
Free cash flow yield1.8%2.5%4.7%4.3%2.5%15.7%
Revenue growth-2.5%-35.8%4.9%-21.6%-35.1%261.8%
Earnings growth-68.6%-147.0%-15.5%-44.3%-42.6%731.4%
Current ratio8.39x14.25x5.40x2.30x1.41x2.46x
Debt to equity0.43x0.42x0.51x0.81x0.44x0.17x
Equity ratio62.5%68.1%63.7%51.7%65.3%74.8%
Interest coverage0.28x-1.00x4.93x11.61x108.00x184.31x
R&D as a share of sales19.6%21.9%14.8%13.1%7.3%3.5%
Buybacks as a share of market value17.1%-5.0%-3.9%1.4%-0.3%0.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-13.1%-19.7%5.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-8.6%13.5%30.6%27.9%
Net margin-10.8%10.8%26.0%24.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-220.0-77.451.365.846.377.7
Price to sales11.512.611.418.117.934.0

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 30 May 2025.

FY2025FY2024FY2023FY2022FY2021
Paid in the year0.250.300.1250.300.25

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.